COSCIENS BIOPHARMA CORP. |
Kanada |
Gesundheit |
CA22112H1010 / A40J1L |
ET8 (Frankfurt) / CSCI (NASDAQ) |
FRA:ET8, ETR:ET8, ET8:GR, NASDAQ:CSCI |
- |
https://www.cosciensbio.c.. |
9.7 Mio. EUR |
7.8 Mio. EUR |
-9.09 Mio. EUR |
-4.718 EUR |
1.93 Mio. EUR |
11.89 Mio. EUR |
-27.1% / - |
- / - |
1.09 / 1.05 / - |
-194.5% / -151.97% |
- |
- / - |
- |
COSCIENS BIOPHARMA, COSCIENS BIO |
17.07.25 |
|